ipoGoogle News
Wall Street Week Ahead: Markets brace for Federal Reserve rate decision - indiaipo.in
Wall Street Week Ahead: Markets brace for Federal Reserve rate decision indiaipo.in
GN2 hours ago
Read More//
PHARMEASY · Health Care · PharmEasy Unlisted / Pre-IPO Share Price
As of 20 Aug 2026, the PharmEasy unlisted share price is ₹6.5 per share (+17.33%). PharmEasy is an unlisted / pre-IPO company — not listed on NSE or BSE. ISIN: INE0DJ201029.
▼ ₹44.5 (−87.25%) over all time
Key figures for PharmEasy
PharmEasy is an Indian digital healthcare platform operated by API Holdings that offers e-pharmacy, diagnostics, teleconsultation and health subscriptions. The platform connects consumers with licensed pharmacies and diagnostic labs, enabling medicine delivery, lab tests at home and electronic records. Corporate communications highlight partnerships with healthcare providers, quality checks, data security and programs aimed at affordability and adherence. PharmEasy has pursued growth through acquisitions and service expansion while emphasizing regulatory compliance and pharmacist-led order verification to support safe access to medicines and diagnostics across Indian cities.
PharmEasy shares are unlisted, so they are bought off-market through a SEBI-registered intermediary rather than on the NSE or BSE. With Safal Capital the process is simple:
No. PharmEasy is currently an unlisted / pre-IPO company, so its shares are not traded on the NSE or BSE and there is no live “PharmEasyshare price NSE”. They are transacted off-market between buyers and sellers through SEBI-registered intermediaries such as Safal Capital.
PharmEasy has not announced a confirmed IPO date. Investors buy unlisted shares ahead of a potential listing for pre-IPO upside, but a listing is never guaranteed and timelines can change. The ISIN for PharmEasy is INE0DJ201029. Contact our desk for the latest status and a live quote before you invest.
PharmEasy is an unlisted company operating in the Health Care sector (E-Pharmacy & Healthtech). PharmEasy is an Indian digital healthcare platform operated by API Holdings that offers e-pharmacy, diagnostics, teleconsultation and health subscriptions. The platform connects consumers with licensed pharmacies and diagnostic labs, enabling medicine delivery, lab tests at home and electronic recor…
The current unlisted market price is ₹5.54 per share with a market capitalisation of approximately ₹9538 crore. The company is currently unlisted and investors should factor in illiquidity risk and longer holding horizons. Investors are advised to review the full financial data and consult an advisor before investing.
Leave your name and mobile, our unlisted shares desk will call you back with live pricing and availability.
As of 20 Aug 2026, the PharmEasy unlisted (pre-IPO) share price is ₹6.5 per share on Safal Capital. Unlisted share prices move with demand, supply and deal size, so contact our desk for a live, deal-specific quote before you transact.
You buy PharmEasy unlisted shares off-market through a SEBI-registered intermediary. With Safal Capital: (1) share your requirement and quantity, (2) we confirm the live price and availability, (3) you complete KYC, (4) transfer funds, and (5) the shares are credited to your demat account, usually within T+1 to T+2 working days.
No. PharmEasy is currently an unlisted / pre-IPO company, so its shares are not traded on the NSE or BSE. They are transacted off-market between buyers and sellers through SEBI-registered intermediaries such as Safal Capital.
PharmEasy has not announced a confirmed IPO date. Unlisted shares are often bought before a potential listing in the hope of pre-IPO gains, but a listing is never guaranteed and timelines can change. Speak to our advisors for the latest status on PharmEasy.
The ISIN for PharmEasy unlisted shares is INE0DJ201029. You will need this ISIN when the shares are credited to your demat account.
PharmEasy unlisted shares have a face value of ₹1 and a typical minimum lot of 5000 shares. Minimum quantities can vary with availability and deal size — our desk will confirm the current lot before you invest.
Unlisted share prices are not set by an exchange. The PharmEasy price reflects recent off-market deals, buyer/seller demand, the company's financials and expectations around a future IPO. Because it is over-the-counter, always confirm a live quote before transacting.
Unlisted shares like PharmEasy can offer pre-IPO upside but carry higher risk and lower liquidity than listed stocks, and there is no guaranteed exit. Invest only after reviewing the company's fundamentals and your risk profile — Safal Capital's SEBI-registered advisors can help you assess PharmEasy.
Latest source-linked updates that may be relevant to this company.
Wall Street Week Ahead: Markets brace for Federal Reserve rate decision indiaipo.in
Invest in US Stocks from India – US Stock Market Today upstox.com
Anthropic selects Nasdaq for IPO amid AI risk concerns indiaipo.in